HYDROXYUREA FOR RECURRENT SURGERY AND RADIATION REFRACTORY MENINGIOMA

被引：0
|
作者：
Chamberlain, Marc C. [1 ]
机构：
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] Phase II trial of imatinib mesylate (GLEEVEC) and hydroxyurea for adults with recurrent/progressive meningioma
    Goli, Krishna
    Bota, Daniela
    Desjardins, Annick
    Rich, Jeremy
    Vredenburgh, James
    Quinn, Jennifer
    Sathornsumetee, Sith
    Salvado, August
    Friedman, Henry
    Reardon, David
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 519 - 519
  • [22] Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma
    David A. Reardon
    Andrew D. Norden
    Annick Desjardins
    James J. Vredenburgh
    James E. Herndon
    April Coan
    John H. Sampson
    Sridharan Gururangan
    Katherine B. Peters
    Roger E. McLendon
    Julie A. Norfleet
    Eric S. Lipp
    Jan Drappatz
    Patrick Y. Wen
    Henry S. Friedman
    [J]. Journal of Neuro-Oncology, 2012, 106 : 409 - 415
  • [23] Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma
    Reardon, David A.
    Norden, Andrew D.
    Desjardins, Annick
    Vredenburgh, James J.
    Herndon, James E., II
    Coan, April
    Sampson, John H.
    Gururangan, Sridharan
    Peters, Katherine B.
    McLendon, Roger E.
    Norfleet, Julie A.
    Lipp, Eric S.
    Drappatz, Jan
    Wen, Patrick Y.
    Friedman, Henry S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 106 (02) : 409 - 415
  • [24] Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review
    Kaley, Thomas
    Barani, Igor
    Chamberlain, Marc
    McDermott, Michael
    Panageas, Katherine
    Raizer, Jeffrey
    Rogers, Leland
    Schiff, David
    Vogelbaum, Michael
    Weber, Damien
    Wen, Patrick
    [J]. NEURO-ONCOLOGY, 2014, 16 (06) : 829 - 840
  • [25] Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma
    Marosi, Christine
    [J]. NEURO-ONCOLOGY, 2015, 17 (01) : 7 - 8
  • [26] Hydroxyurea Chemotherapy for Unresectable or Residual Meningioma
    Herbert B. Newton
    Mary A. Slivka
    Carol Stevens
    [J]. Journal of Neuro-Oncology, 2000, 49 : 165 - 170
  • [27] Hydroxyurea chemotherapy for unresectable or residual meningioma
    Newton, HB
    Slivka, MA
    Stevens, C
    [J]. ANNALS OF NEUROLOGY, 1999, 46 (03) : 493 - 493
  • [28] Hydroxyurea chemotherapy for unresectable or residual meningioma
    Newton, HB
    Slivka, MA
    Stevens, C
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2000, 49 (02) : 165 - 170
  • [29] RECURRENT MENINGIOMA
    BOYLAN, SE
    MCCUNNIFF, AJ
    [J]. CANCER, 1988, 61 (07) : 1447 - 1452
  • [30] A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
    Kumthekar, Priya
    Grimm, Sean Aaron
    Aleman, Roxanne T.
    Chamberlain, Marc C.
    Schiff, David
    Wen, Patrick Y.
    Iwamoto, Fabio Massaiti
    Gursel, Demirkan Besim
    Reardon, David A.
    Purow, Benjamin
    Kocherginski, Masha
    Helenowski, Irene
    Raizer, Jeffrey J.
    [J]. NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
12345